Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Pilot RNAi screening using mammalian cell-based system identifies novel putative silencing factors including Kat5/Tip60

1 Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom;
2 Department of Biosciences, P.O. Box 65 (Viikkinkaari 1), 00014, University of Helsinki, Finland;
3 Center for Cancer Research, National Cancer Institute, Building 37, Room 5032A, Bethesda, MD 20892, USA

Special Issues: Chromatin and Epigenetics

Epigenetic silencing is the reversible inactivation of a gene transcription which occurs as a result of changes in the structure of the chromatin that can be successfully inherited from parent to daughter cells. It involves non-genetic mutations within the genome, as well as post-transcriptional and post-translational mechanisms. Existence of these mechanisms at various levels warrants their role in development and disease and thus it is crucial to study different factors and mechanisms of silencing. The aim of our study was to establish a method for rapid screening for the loss of epigenetic silencing in mammalian cells, to identify factor(s) involved in epigenetic silencing, and to get insights into their mechanism of action. For this purpose, we used RNAi screening approach using shRNAs that targeted our genes of interest. We employed a modified mouse cell line which contained a GFP transgene under the control of CMV promoter which has been silenced by epigenetic modifications. Our screening identified several proteins as epigenetic silencing regulators including Kat5/Tip60, an acetyltransferase of MYST family of proteins. To characterize its function, we performed preliminary experiments using microscopy and Western blot analysis of histone marks. We observed changes in H4 acetylation levels in Kat5/Tip60 knockdown cells. Our study thus serves as a pilot for a genome-wide silencing screening using mammalian cells, and provides preliminary results suggesting that Kat5 can be considered as a silencing factor, which, we propose, could function by maintaining H4 acetylation patterns.
  Figure/Table
  Supplementary
  Article Metrics

References

1. Schubert T, Langst G (2015) Studying epigenetic interactions using MicroScale Thermophoresis (MST). AIMS Biophys 2: 370-380.    

2. Sutherland JE, Costa M (2003) Epigenetics and the environment. Ann N Y Acad Sci 983: 151-160.    

3. Teif VB, Rippe K (2011) Nucleosome mediated crosstalk between transcription factors at eukaryotic enhancers. Phys Biol 8: 044001.    

4. Urnov FD, Wolffe AP (2001) Above and within the genome: Epigenetics past and present. J Mammary Gland Biol Neoplasia 6: 153-167.    

5. Kim YZ (2014) Altered histone modifications in gliomas. Brain tumor Res Treat 2: 7-21.    

6. Paszkowski J, Whitham S a. (2001) Gene silencing and DNA methylation processes. Curr Opin Plant Biol 4: 123-129.    

7. Adam S, Polo SE (2014) Blurring the line between the DNA damage response and transcription: The importance of chromatin dynamics. Exp Cell Res 329: 148-153.    

8. Morey L, Santanach A, Di Croce L (2015) Pluripotency and epigenetic factors in mouse embryonic stem cell fate regulation. Mol Cell Biol 35: MCB.00266-15.

9. Hassan MQ, Tye CE, Stein GS, et al. (2015) Non-coding RNAs: Epigenetic regulators of bone development and homeostasis. Bone pii: S8756-3282(15)00207-0.

10. Easwaran H, Tsai HC, Baylin SB (2014) Cancer epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance. Mol Cell 716-727.

11. Sui X, Zhu J, Zhou J, et al. (2015) Epigenetic modifications as regulatory elements of autophagy in cancer. Cancer Lett 360: 106-113.

12. Rizki G, Boyer LA (2015) Lncing Epigenetic Control of Transcription to Cardiovascular Development and Disease. Circ Res 700-714.

13. Zhang Z, Zhang R (2015) Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmun Rev.

14. Bajpe PK, Prahallad A, Horlings H, et al. (2014) A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity. Oncogene 1-6.

15. Zhdanov R, Schirmer EC, Venkatasubramani AV, et al. (2015) Lipids contribute to epigenetic control via chromatin structure and functions. Zhdanov et al. Science Open Research 2015 (DOI: 10.14293/S2199-1006.1.SOR-LIFE.AUXYTR.v1).

16. Ahmad K, Henikoff S (2002) The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 9: 1191-1200.

17. Maze I, Wenderski W, Noh K-M, et al. (2015) Critical Role of Histone Turnover in Neuronal Transcription and Plasticity. Neuron 87: 77-94.    

18. Udugama M, Chang FTM, Chan FL, et al. (2015) Histone variant H3.3 provides the heterochromatic H3 lysine 9 tri-methylation mark at telomeres. Nucleic Acids Res 1-11.

19. Kimura A, Horikoshi M (1998) Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3: 789-800.    

20. Martinez ED, Dull AB, Beutler J a., et al. (2006) High-Content Fluorescence-Based Screening for Epigenetic Modulators. Methods Enzymol 414: 21-36.    

21. Carpenter AE, Jones TR, Lamprecht MR, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100.    

22. Latham T, MacKay L, Sproul D, et al. (2012) Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res 40: 4794-4803.    

23. Braunstein M, Sobel RE, Allis CD, et al. (1996) Efficient transcriptional silencing in Saccharomyces cerevisiae requires a heterochromatin histone acetylation pattern. Mol Cell Biol 16: 4349-4356.    

24. Tong K, Keller T, Hoffman CS, et al. (2012) Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing. Eukaryot Cell 11: 1095-1103.    

25. Yang Y, Lu Y, Espejo A, et al. (2010) TDRD3 Is an Effector Molecule for Arginine-Methylated Histone Marks. Mol Cell 40: 1016-1023.    

26. Ying M, Chen D (2012) Tudor domain-containing proteins of Drosophila melanogaster. Dev Growth Differ 54: 32-43.    

27. Galarneau L, Nourani A, Boudreault AA, et al. (2000) Multiple links between the NuA4 histone acetyltransferase complex and epigenetic control of transcription. Mol Cell 5: 927-937.    

28. Zhao H, Jin S, Gewirtz AM (2012) The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia. J Biol Chem 287: 925-934.    

29. Ai W, Zheng H, Yang X, et al. (2007) Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity. Nucleic Acids Res 35: 6137-6149.    

30. Gupta A, Jha S, Engel DA, et al. (2013) Tip60 degradation of aenovirus relieves transciptional repression of viral transcriptional activator EIA. Oncogene 42: 5017-5025.

31. Kim M-Y, Ann E-J, Kim J-Y, et al. (2007) Tip60 histone acetyltransferase acts as a negative regulator of Notch1 signaling by means of acetylation. Mol Cell Biol 27: 6506-6519.

32. Kaidi A, Jackson SP (2013) KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature 498: 70-74.

33. Shogren-Knaak M, Ishii H, Sun J-M, et al. (2006) Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844-847.    

34. Braunstein M, Rose AB, Holmes SG, et al. (1993) Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev 7: 592-604.    

35. Sharma GG, So S, Gupta A, et al. (2010) MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair. Mol Cell Biol 30: 3582-3595.    

Copyright Info: © 2015, Alexander Kagansky, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved